Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Becton, Dickinson and Company BDX

Healthcare  —  Medical Instruments & Supplies
183.82 4.59 2.56% as of 25 Sep
Market cap
$48.8B
P/E
55.4×
S&P 500 Member Dividend Aristocrat Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Becton, Dickinson and Company (BDX) EV/EBITDA

As of 25 September 2026, Becton, Dickinson and Company (BDX) trades at a EV/EBITDA of 13.3×. Over the past ten years it has ranged from 10.1× (January 2015) to 33.5× (June 2018); the current reading is higher than 17% of that period. That is below the Medical Instruments & Supplies industry median of 16.1× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 11.7× (22.08%)
FY2024 15.1× (7.01%)
FY2023 16.2× 16.67%
FY2022 13.9× (10.16%)
FY2021 15.5× (26.99%)
FY2020 21.2× 21.63%
FY2019 17.4× (13.35%)
FY2018 20.1× 40.04%
FY2017 14.3× (3.90%)
FY2016 14.9× (3.73%)

Quarterly

Period EV/EBITDA Change
Jun 2026 11.4× (4.46%)
Mar 2026 11.9× 3.16%
Dec 2025 11.6× (1.54%)
Sep 2025 11.7× (5.14%)
42 more quarters

Against its own ten years

Low 10.1× High 33.5×
Ten-year median 15.6×
Current reading's percentile 17

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 3.9×
SOLV Solventum Corporation compare 7.9×
ALC Alcon compare 12.7×
BDX Becton, Dickinson and Company 13.3×
BAX Baxter International Inc. compare 13.3×
RMD ResMed Inc. compare 14.7×
WST West Pharmaceutical Services, Inc. compare 30.2×
ISRG Intuitive Surgical, Inc. compare 32.5×
RGEN Repligen Corporation compare 65.3×
Medical Instruments & Supplies industry median 16.1×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BDX